Related Experiment Videos
Primary melanoma of urinary bladder
H Van Ahlen1, V Nicolas, W Lenz
1Department of Urology, University of Bonn, Germany.
Urology
|December 1, 1992
Summary
Primary bladder melanoma, a rare cancer, was successfully treated in an elderly patient using radiation and recombinant alpha 2 interferon. This combination therapy offers a potential alternative to surgery for select patients, achieving complete remission.
Area of Science:
- Urology
- Oncology
- Dermatology
Background:
- Primary malignant melanoma of the bladder is an extremely rare urologic malignancy.
- Literature review indicates limited established treatment protocols for this condition.
Observation:
- A case report of the fourth documented instance of primary bladder melanoma in an 81-year-old female patient.
- The patient was deemed unsuitable for extensive surgical intervention due to age and comorbidities.
Findings:
- Successful treatment utilizing a combination of radiation therapy and immunotherapy with recombinant alpha 2 interferon.
- The patient achieved complete remission lasting 15 months post-treatment initiation, following monthly tumor recurrences.
Implications:
- This therapeutic approach may represent a viable, less invasive alternative to radical surgery for elderly patients with primary bladder melanoma.
- Further research into immunotherapy and radiation combinations for rare urologic tumors is warranted.